Finanzwire Finanzwire
Basculer en Français
10816 Companies
234406 Keywords
163263 Articles
125412 Press releases
Headlines Articles Press releases Biophytis Remove
  1. Home
  2. Companies
  3. Biophytis
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/31/2023 at 08:00, 3 years 6 months ago

    Biophytis publishes its financial results for the first half of 2022

    Logo of Biophytis
  • PRESS RELEASE

    published on 01/19/2023 at 00:00, 3 years 6 months ago

    Biophytis: Judgment of the Paris Court of Appeal of 17 January 2023 in the case between Biophytis and Negma Group Ltd

    Logo of Biophytis
  • PRESS RELEASE

    published on 01/12/2023 at 08:00, 3 years 6 months ago

    Biophytis to take appropriate measures after receiving Nasdaq deficiency notice

    Logo of Biophytis
  • PRESS RELEASE

    published on 01/05/2023 at 08:00, 3 years 7 months ago

    Biophytis announces its participation in two major investor conferences in January, in the United States and in France: the JP Morgan Healthcare Conference and the Invest Securities Biomed

    Logo of Biophytis
Previous page
1 ... 26 27
Accesswire
  • Published on 08/10/2026 at 20:30, 12 minutes ago

    Clean Air Metals and Fiore-backed Springbok Ventures Announce Upsize of Non-Brokered Private Placement

  • Published on 08/10/2026 at 15:30, 5 hours 12 minutes ago

    Silver Spruce Resources, Inc. Announces New Chief Financial Officer

  • Published on 08/10/2026 at 15:25, 5 hours 17 minutes ago

    Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland

  • Published on 08/10/2026 at 14:30, 6 hours 12 minutes ago

    NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak

  • Published on 08/10/2026 at 13:30, 7 hours 12 minutes ago

    Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq

View all ACCESSWIRE
EQS Group
  • Published on 08/10/2026 at 20:24, 18 minutes ago

    EQS-Adhoc: PNE AG updates on ongoing sales process

  • Published on 08/10/2026 at 19:35, 1 hour 7 minutes ago

    Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly

  • Published on 08/10/2026 at 18:29, 2 hours 13 minutes ago

    Fuller, Smith & Turner PLC: Director/PDMR Shareholdings

  • Published on 08/10/2026 at 17:50, 2 hours 52 minutes ago

    Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report

  • Published on 08/10/2026 at 17:38, 3 hours 4 minutes ago

    PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 2 hours 42 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 2 hours 57 minutes ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 8 hours 48 minutes ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 9 hours 6 minutes ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 11 hours 20 minutes ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy